Abbott Sells its Vision Unit to J&J

Discussion in 'Abbott' started by RobertPhillips900, Sep 16, 2016 at 4:48 PM.

  1. RobertPhillips900

    Joined:
    Aug 29, 2016
    Messages:
    51
    Likes Received:
    0
    Abbott is most often rated as a stand-out health care stock. It is the diversified revenue stream that makes Abbott a stable company. The company off lately has been in news for its proposed acquisition of Alere Inc, a medical testing company and St. Jude Medical Inc, a device maker.

    Abbott is clearing space for the acquisition by selling its eye surgery equipment unit to Johnson & Johnson for $3.44Bil. The deal is expected to close in the first quarter of 2017.

    There is a positive reaction to Abbott stock on this move.